Double maintains 1 strategies that include DYN - Dyne Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SVV | -0.01% | $1.62B | -16.09% | 0.00% |
NHTC | 0.12% | $49.85M | -39.01% | 18.21% |
MSEX | 0.20% | $976.83M | +4.31% | 2.48% |
VHC | -0.23% | $45.90M | +59.26% | 0.00% |
G | 0.30% | $7.61B | +35.26% | 1.47% |
ALHC | 0.37% | $2.74B | +77.11% | 0.00% |
CHD | -0.59% | $23.34B | -8.58% | 1.22% |
CL | -0.62% | $71.89B | -8.58% | 2.28% |
LRN | -0.63% | $6.34B | +106.55% | 0.00% |
GFI | -0.75% | $20.47B | +53.49% | 2.38% |
EXC | -0.79% | $43.32B | +23.98% | 3.65% |
AMT | 0.81% | $101.95B | +12.04% | 3.05% |
TDUP | -0.82% | $880.94M | +338.24% | 0.00% |
KR | -0.82% | $47.56B | +43.04% | 1.79% |
PSQH | 0.85% | $93.81M | -45.36% | 0.00% |
NAT | 0.88% | $571.73M | -32.16% | 15.33% |
ZCMD | -0.94% | $28.79M | -13.64% | 0.00% |
CALM | 0.95% | $5.28B | +62.26% | 6.80% |
VITL | 0.99% | $1.73B | -16.98% | 0.00% |
LFVN | 1.08% | $159.74M | +97.66% | 1.30% |
Yahoo
The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.80%. September E-mini S&P futures (ESU25 ) are down -0.28%, and September E-mini Nasdaq futures...
Yahoo
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively tr
Yahoo
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of an underwritten public offering of 24,242,425 shares of its common stock at a public offering price of $8.25 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses
Yahoo
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has commenced an underwritten public offering of $200,000,000 of shares of its common stock. Dyne also intends to grant the underwriters a 30-day option to purchase up to an additional $30,000,000 of shares of its common stock. All of the shares in th
Yahoo
- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced it has entered into a $275 million non-dilutive senior secured term loan facility with Hercules Capital, Inc. (NYSE: HTGC)
Finnhub
Dyne Therapeutics, Inc. added to Russell 3000 Value Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RNA | 59.63% | $3.50B | -28.94% | 0.00% |
CRNX | 55.71% | $2.81B | -33.11% | 0.00% |
XNCR | 53.05% | $579.33M | -57.00% | 0.00% |
RVMD | 51.66% | $6.88B | -4.90% | 0.00% |
SYRE | 51.63% | $918.58M | -35.26% | 0.00% |
NRIX | 49.50% | $887.38M | -44.23% | 0.00% |
OCUL | 49.10% | $1.47B | +34.80% | 0.00% |
APGE | 48.96% | $2.58B | +10.24% | 0.00% |
RGNX | 48.59% | $422.76M | -28.29% | 0.00% |
IDYA | 48.21% | $1.87B | -39.13% | 0.00% |
ROIV | 48.04% | $7.74B | +7.76% | 0.00% |
KYMR | 47.69% | $2.87B | +47.81% | 0.00% |
RARE | 47.59% | $3.45B | -11.14% | 0.00% |
ARWR | 46.64% | $2.22B | -38.13% | 0.00% |
JEF | 46.30% | $11.50B | +12.04% | 2.66% |
QTWO | 46.23% | $5.86B | +55.79% | 0.00% |
ATXS | 45.89% | $314.34M | -38.79% | 0.00% |
DNLI | 45.66% | $2.05B | -39.28% | 0.00% |
ZYME | 44.96% | $876.06M | +46.53% | 0.00% |
SNDX | 44.90% | $777.87M | -55.97% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 60.24% | $4.95B | 0.35% |
GNOM | 56.60% | $44.43M | 0.5% |
IBB | 53.87% | $5.36B | 0.45% |
PTH | 50.37% | $101.07M | 0.6% |
PBE | 50.20% | $223.24M | 0.58% |
IWC | 48.44% | $824.65M | 0.6% |
BBH | 47.68% | $329.82M | 0.35% |
IWO | 47.35% | $11.48B | 0.24% |
KJUL | 46.86% | $120.75M | 0.79% |
XPH | 46.81% | $149.79M | 0.35% |
ARKG | 46.30% | $1.05B | 0.75% |
FBT | 46.26% | $1.01B | 0.54% |
IWM | 46.24% | $64.00B | 0.19% |
VTWO | 46.23% | $13.29B | 0.07% |
KJAN | 45.98% | $289.38M | 0.79% |
RDTE | 45.52% | $138.47M | 0.97% |
SCHA | 45.17% | $17.26B | 0.04% |
GSSC | 44.57% | $586.95M | 0.2% |
PINK | 44.56% | $133.06M | 0.5% |
NUSC | 44.47% | $1.13B | 0.31% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -39.15% | $165.69M | 0.85% |
TAIL | -34.35% | $99.76M | 0.59% |
BTAL | -32.26% | $296.79M | 1.43% |
FXY | -14.43% | $815.67M | 0.4% |
BILS | -10.47% | $3.86B | 0.1356% |
XHLF | -9.68% | $1.73B | 0.03% |
IVOL | -9.59% | $349.27M | 1.02% |
CORN | -9.12% | $44.21M | 0.2% |
WEAT | -8.79% | $117.15M | 0.28% |
GBIL | -8.74% | $6.38B | 0.12% |
FTSD | -8.54% | $231.79M | 0.25% |
BIL | -8.46% | $42.87B | 0.1356% |
TFLO | -7.61% | $6.83B | 0.15% |
XONE | -7.60% | $585.86M | 0.03% |
SPTS | -7.45% | $5.78B | 0.03% |
CLIP | -7.28% | $1.52B | 0.07% |
SGOV | -7.06% | $49.84B | 0.09% |
JMST | -7.03% | $4.06B | 0.18% |
TBIL | -6.33% | $5.84B | 0.15% |
GOVT | -6.25% | $27.51B | 0.05% |
Current Value
$8.731 Year Return
Current Value
$8.731 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.42% | $23.98B | +34.66% | 1.10% |
COR | -11.50% | $58.03B | +32.90% | 0.72% |
DFDV | -9.78% | $247.94M | +1,821.34% | 0.00% |
HUSA | -9.58% | $22.94M | -6.82% | 0.00% |
ED | -9.38% | $35.36B | +9.76% | 3.39% |
AEP | -7.66% | $54.73B | +16.78% | 3.58% |
STG | -7.05% | $29.06M | -28.79% | 0.00% |
WBA | -6.45% | $9.91B | -5.33% | 4.37% |
RPRX | -6.15% | $15.11B | +36.03% | 2.40% |
MUSA | -5.80% | $8.06B | -13.12% | 0.47% |
GALT | -5.59% | $147.47M | +3.10% | 0.00% |
MOH | -5.08% | $16.10B | -0.08% | 0.00% |
AXGN | -4.93% | $478.21M | +45.03% | 0.00% |
CNC | -4.82% | $26.87B | -18.57% | 0.00% |
NOC | -4.56% | $71.10B | +13.32% | 1.72% |
PGNY | -4.51% | $1.88B | -23.42% | 0.00% |
T | -4.41% | $202.05B | +46.94% | 3.95% |
MCK | -4.31% | $90.65B | +24.27% | 0.39% |
VZ | -4.30% | $178.39B | +2.59% | 6.38% |
MO | -4.12% | $98.96B | +28.98% | 6.98% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TDTT | 0.07% | $2.63B | 0.18% |
TOTL | -0.11% | $3.87B | 0.55% |
BNDX | -0.14% | $67.37B | 0.07% |
UBND | -0.26% | $1.02B | 0.4% |
CARY | 0.33% | $347.36M | 0.8% |
CGCB | 0.39% | $2.47B | 0.27% |
LDUR | 0.46% | $929.55M | 0.5% |
CMBS | 0.47% | $446.84M | 0.25% |
BUXX | -0.64% | $318.71M | 0.25% |
JBND | -0.66% | $2.31B | 0.25% |
GTIP | 0.67% | $164.35M | 0.12% |
LGOV | -0.72% | $708.16M | 0.67% |
STXT | 0.73% | $129.73M | 0.49% |
SCHP | 0.73% | $13.50B | 0.03% |
SHY | -0.75% | $24.08B | 0.15% |
PALL | 0.78% | $494.87M | 0.6% |
BWX | -0.81% | $1.53B | 0.35% |
BSMW | -0.84% | $107.26M | 0.18% |
BSV | 0.85% | $38.37B | 0.03% |
HTRB | 0.91% | $2.03B | 0.29% |